(AUPH) Aurinia Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Aurinia Pharmaceuticals | (AUPH) share price targets
Complete technical analysis of Aurinia Pharmaceuticals (AUPH) by charts plus indicators, forecast predictions and share price targets for Aurinia Pharmaceuticals (AUPH)
Aurinia Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-12 View latest technical analysis
10 day averaged volume of Aurinia Pharmaceuticals is 2268291
| Date | Daily Closing Price | Open | High | Low | Volume |
| 12 Wed Mar 2025 | 8.15 | 8.31 | 8.39 | 8.07 | 0.741 times |
| 11 Tue Mar 2025 | 8.29 | 8.23 | 8.36 | 8.04 | 0.894 times |
| 10 Mon Mar 2025 | 8.17 | 8.08 | 8.23 | 7.92 | 0.723 times |
| 07 Fri Mar 2025 | 8.15 | 8.19 | 8.34 | 8.04 | 0.508 times |
| 06 Thu Mar 2025 | 8.19 | 8.63 | 8.71 | 8.15 | 0.693 times |
| 05 Wed Mar 2025 | 8.68 | 8.10 | 8.84 | 8.10 | 1.018 times |
| 04 Tue Mar 2025 | 8.08 | 7.95 | 8.14 | 7.76 | 1.599 times |
| 03 Mon Mar 2025 | 7.98 | 7.97 | 8.14 | 7.79 | 1.139 times |
| 28 Fri Feb 2025 | 7.95 | 7.47 | 7.95 | 7.47 | 0.816 times |
| 27 Thu Feb 2025 | 7.55 | 7.73 | 7.75 | 6.55 | 1.98 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 8.2 as stoploss in an intra day sell trade for a target of 8.02. However, stock will show a bullish move above 8.2.
Share price targets for Aurinia Pharmaceuticals (AUPH)
| Target Type | Value |
| Downside Target | 6.55 |
| Downside Target | 7.03 |
| Downside Target | 7.47 |
| Downside Target | 7.76 |
| Downside Target | 7.92 |
| Downside Target | 8.10 |
| Upside Target | 8.39 |
| Upside Target | 8.84 |
| Upside Target | 8.87 |
| Upside Target | 9.04 |
| Upside Target | 9.10 |
| Upside Target | 10.67 |
Intraday share price targets for Aurinia Pharmaceuticals (AUPH)
| Target Type | Value |
| Downside Intraday Target | 7.92 |
| Downside Intraday Target | 7.68 |
| Upside Intraday Target | 8.39 |
| Upside Intraday Target | 8.62 |
| Upside Intraday Target | 8.15 |
Weekly technical analysis of Aurinia Pharmaceuticals (AUPH)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 12 Wed Mar 2025 | 8.15 | 8.08 | 8.39 | 7.92 | 0.476 times |
| 07 Fri Mar 2025 | 8.15 | 7.97 | 8.84 | 7.76 | 1.094 times |
| 28 Fri Feb 2025 | 7.95 | 7.92 | 8.20 | 6.55 | 2.204 times |
| 21 Fri Feb 2025 | 7.93 | 7.89 | 8.10 | 7.50 | 0.862 times |
| 14 Fri Feb 2025 | 7.79 | 8.02 | 8.12 | 7.47 | 1.053 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Aurinia Pharmaceuticals (AUPH)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 12 Wed Mar 2025 | 8.15 | 7.97 | 8.84 | 7.76 | 0.651 times |
| 28 Fri Feb 2025 | 7.95 | 7.82 | 8.33 | 6.55 | 0.829 times |
| 31 Fri Jan 2025 | 7.95 | 9.05 | 9.10 | 7.52 | 1.404 times |
| 31 Tue Dec 2024 | 8.96 | 8.94 | 10.67 | 8.87 | 0.733 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aurinia Pharmaceuticals (AUPH)
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Aurinia Pharmaceuticals in short term and the buy signal is strong.
Aurinia Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aurinia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.06 and Aurinia Pharmaceuticals (AUPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Aurinia Pharmaceuticals ( (AUPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Aurinia Pharmaceuticals in short term and the buy signal is strong.
Aurinia Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Aurinia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.06 and Aurinia Pharmaceuticals (AUPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aurinia Pharmaceuticals (AUPH) stock. Volume based technical analysis of Aurinia Pharmaceuticals (AUPH) stock is negative.
Aurinia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.